Antipsychotic-Induced Dopamine Supersensitivity Psychosis: Pharmacology, Criteria, and Therapy
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Antipsychotic-Induced Dopamine Supersensitivity Psychosis: Pharmacology, Criteria, and Therapy
Authors
Keywords
-
Journal
PSYCHOTHERAPY AND PSYCHOSOMATICS
Volume 86, Issue 4, Pages 189-219
Publisher
S. Karger AG
Online
2017-06-24
DOI
10.1159/000477313
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Efficacy of clozapine on dopamine supersensitivity psychosis in schizophrenia
- (2017) Yusuke Nakata et al. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
- Risperidone long-acting injectable in the treatment of treatment-resistant schizophrenia with dopamine supersensitivity psychosis: Results of a 2-year prospective study, including an additional 1-year follow-up
- (2016) Hiroshi Kimura et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Factors associated with overweight and obesity in schizophrenia, schizoaffective and bipolar disorders
- (2016) Virginie-Anne Chouinard et al. PSYCHIATRY RESEARCH
- Update on the Mechanism of Action of Aripiprazole: Translational Insights into Antipsychotic Strategies Beyond Dopamine Receptor Antagonism
- (2015) Andrea de Bartolomeis et al. CNS DRUGS
- The Pharmacokinetics of Second-Generation Long-Acting Injectable Antipsychotics: Limitations of Monograph Values
- (2015) Lik Hang N. Lee et al. CNS DRUGS
- 5-HT2 receptors modulate the expression of antipsychotic-induced dopamine supersensitivity
- (2015) Alexandra Charron et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Alterations of Dopamine D2 Receptors and Related Receptor-Interacting Proteins in Schizophrenia: The Pivotal Position of Dopamine Supersensitivity Psychosis in Treatment-Resistant Schizophrenia
- (2015) Yasunori Oda et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- G protein-coupled receptor kinase 6/β-arrestin 2 system in a rat model of dopamine supersensitivity psychosis
- (2015) Yasunori Oda et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Dopamine supersensitivity psychosis and dopamine partial agonist: A retrospective survey of failure of switching to aripiprazole in schizophrenia
- (2015) Masayuki Takase et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Antipsychotic treatment leading to dopamine supersensitivity persistently alters nucleus accumbens function
- (2015) Cynthia El Hage et al. NEUROPHARMACOLOGY
- Dopamine D3 receptor antagonism contributes to blonanserin-induced cortical dopamine and acetylcholine efflux and cognitive improvement
- (2015) Mei Huang et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- Psychotropic dose equivalence in Japan
- (2015) Toshiya Inada et al. PSYCHIATRY AND CLINICAL NEUROSCIENCES
- Dopamine supersensitivity psychosis as a pivotal factor in treatment-resistant schizophrenia
- (2015) Tomotaka Suzuki et al. PSYCHIATRY RESEARCH
- Withdrawal Symptoms after Selective Serotonin Reuptake Inhibitor Discontinuation: A Systematic Review
- (2015) Giovanni A. Fava et al. PSYCHOTHERAPY AND PSYCHOSOMATICS
- New Classification of Selective Serotonin Reuptake Inhibitor Withdrawal
- (2015) Guy Chouinard et al. PSYCHOTHERAPY AND PSYCHOSOMATICS
- Hypnotics and Triazolobenzodiazepines - Best Predictors of High-Dose Benzodiazepine Use: Results from the Luxembourg National Health Insurance Registry
- (2015) Jean-Marc Cloos et al. PSYCHOTHERAPY AND PSYCHOSOMATICS
- Challenging the need for sustained blockade of dopamine D2 receptor estimated from antipsychotic plasma levels in the maintenance treatment of schizophrenia: A single-blind, randomized, controlled study
- (2015) Takashi Tsuboi et al. SCHIZOPHRENIA RESEARCH
- Efficacy and safety of aripiprazole once-monthly in Asian patients with schizophrenia: A multicenter, randomized, double-blind, non-inferiority study versus oral aripiprazole
- (2015) Jun Ishigooka et al. SCHIZOPHRENIA RESEARCH
- Dose and Dosing Frequency of Long-Acting Injectable Antipsychotics
- (2014) Hiroyuki Uchida et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Drugs of abuse and psychiatric disorders: Neurobiological and clinical aspects
- (2014) Anne-Noël Samaha et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Persistent Postwithdrawal Disorders Induced by Paroxetine, a Selective Serotonin Reuptake Inhibitor, and Treated with Specific Cognitive Behavioral Therapy
- (2014) Carlotta Belaise et al. PSYCHOTHERAPY AND PSYCHOSOMATICS
- A prospective comparative study of risperidone long-acting injectable for treatment-resistant schizophrenia with dopamine supersensitivity psychosis
- (2014) Hiroshi Kimura et al. SCHIZOPHRENIA RESEARCH
- Withdrawal Symptoms and Rebound Syndromes Associated with Switching and Discontinuing Atypical Antipsychotics: Theoretical Background and Practical Recommendations
- (2013) Anja Cerovecki et al. CNS DRUGS
- Schizophrenia and dopamine receptors
- (2013) Philip Seeman EUROPEAN NEUROPSYCHOPHARMACOLOGY
- 2804 – Asenapine after clozapine: is possible?
- (2013) P. Matteo et al. EUROPEAN PSYCHIATRY
- Optimal Extent of Dopamine D2 Receptor Occupancy by Antipsychotics for Treatment of Dopamine Supersensitivity Psychosis and Late-Onset Psychosis
- (2013) Masaomi Iyo et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Antipsychotic Polypharmacy in a Treatment-Refractory Schizophrenia Population Receiving Adjunctive Treatment With Electroconvulsive Therapy
- (2013) Diana Kristensen et al. JOURNAL OF ECT
- Comparative effect of lurasidone and blonanserin on cortical glutamate, dopamine, and acetylcholine efflux: role of relative serotonin (5-HT)2Aand DA D2antagonism and 5-HT1Apartial agonism
- (2013) Mei Huang et al. JOURNAL OF NEUROCHEMISTRY
- Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis
- (2013) Stefan Leucht et al. LANCET
- Can antipsychotic treatment contribute to drug addiction in schizophrenia?
- (2013) Anne-Noël Samaha PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Is schizophrenia a dopamine supersensitivity psychotic reaction?
- (2013) Mary V. Seeman et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Potential treatment strategy of risperidone in long-acting injectable form for schizophrenia with dopamine supersensitivity psychosis
- (2013) Hiroshi Kimura et al. SCHIZOPHRENIA RESEARCH
- Serotonin Syndrome Associated With Clozapine Withdrawal
- (2013) Elizabeth Stevenson et al. JAMA Neurology
- Chronic H1-Antihistamine Treatment Increases Seizure Susceptibility After Withdrawal by Impairing Glutamine Synthetase
- (2012) Wei-Wei Hu et al. CNS Neuroscience & Therapeutics
- Striatal dopamine release in schizophrenia comorbid with substance dependence
- (2012) J L Thompson et al. MOLECULAR PSYCHIATRY
- Blonanserin, a novel atypical antipsychotic agent not actively transported as substrate by P-glycoprotein
- (2012) Tomoko Inoue et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Patient Online Report of Selective Serotonin Reuptake Inhibitor-Induced Persistent Postwithdrawal Anxiety and Mood Disorders
- (2012) Carlotta Belaise et al. PSYCHOTHERAPY AND PSYCHOSOMATICS
- Prior Haloperidol, but not Olanzapine, Exposure Augments the Pursuit of Reward Cues: Implications for Substance Abuse in Schizophrenia
- (2012) Anne-Marie Bédard et al. SCHIZOPHRENIA BULLETIN
- Quetiapine Extended Release
- (2011) Mark Sanford CNS DRUGS
- Antipsychotic Drugs Rapidly Induce Dopamine Neuron Depolarization Block in a Developmental Rat Model of Schizophrenia
- (2011) O. Valenti et al. JOURNAL OF NEUROSCIENCE
- Continuous, but not Intermittent, Antipsychotic Drug Delivery Intensifies the Pursuit of Reward Cues
- (2011) Anne-Marie Bédard et al. NEUROPSYCHOPHARMACOLOGY
- Chronic Treatment With Aripiprazole Prevents Development of Dopamine Supersensitivity and Potentially Supersensitivity Psychosis
- (2011) S. Tadokoro et al. SCHIZOPHRENIA BULLETIN
- Antipsychotic treatment for schizophrenia in the maintenance phase: A systematic review of the guidelines and algorithms
- (2011) Hiroyoshi Takeuchi et al. SCHIZOPHRENIA RESEARCH
- Dopamine agonist radioligand binds to both D2High and D2Low receptors, explaining why alterations in D2High are not detected in human brain scans
- (2011) Philip Seeman SYNAPSE
- All Roads to Schizophrenia Lead to Dopamine Supersensitivity and Elevated Dopamine D2High Receptors
- (2010) Philip Seeman CNS Neuroscience & Therapeutics
- “Extended” Antipsychotic Dosing in the Maintenance Treatment of Schizophrenia
- (2010) Gary Remington et al. JOURNAL OF CLINICAL PSYCHIATRY
- A naturalistic controlled study of relapsing schizophrenic patients with tardive dyskinesia and supersensitivity psychosis
- (2010) Paul Fallon et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Agonist-Induced Endocytosis and Receptor Phosphorylation Mediate Resensitization of Dopamine D2Receptors
- (2010) Dongim Cho et al. MOLECULAR ENDOCRINOLOGY
- Increased left striatal dopamine transmission in unaffected siblings of schizophrenia patients in response to acute metabolic stress
- (2010) Jerome Brunelin et al. PSYCHIATRY RESEARCH-NEUROIMAGING
- Long-term haloperidol treatment (but not risperidone) enhances addiction-related behaviors in mice: role of dopamine D2 receptors
- (2009) Rita C. Carvalho et al. ADDICTION BIOLOGY
- Extended-release quetiapine fumarate (quetiapine XR): a once-daily monotherapy effective in generalized anxiety disorder. Data from a randomized, double-blind, placebo- and active-controlled study
- (2009) Borwin Bandelow et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- The role of intrusive and other recent life events on symptomatology in relapses of schizophrenia: a community nursing investigation
- (2009) P. FALLON Journal of Psychiatric and Mental Health Nursing
- Less Is More: Antipsychotic Drug Effects Are Greater with Transient Rather Than Continuous Delivery
- (2008) Anne-Noël Samaha et al. BIOLOGICAL PSYCHIATRY
- Haloperidol (but not ziprasidone) withdrawal potentiates sensitization to the hyperlocomotor effect of cocaine in mice
- (2008) Daniela Fukue Fukushiro et al. BRAIN RESEARCH BULLETIN
- Asenapine: a novel psychopharmacologic agent with a unique human receptor signature
- (2008) M. Shahid et al. JOURNAL OF PSYCHOPHARMACOLOGY
- The Dopamine D2 Receptors in High-Affinity State and D3 Receptors in Schizophrenia: A Clinical [11C]-(+)-PHNO PET Study
- (2008) Ariel Graff-Guerrero et al. NEUROPSYCHOPHARMACOLOGY
- D2-Receptor Upregulation is Dependent upon Temporal Course of D2-Occupancy: A Longitudinal [11C]-Raclopride PET Study in Cats
- (2008) Nathalie Ginovart et al. NEUROPSYCHOPHARMACOLOGY
- Atypical Antipsychotics: CATIE Study, Drug-Induced Movement Disorder and Resulting Iatrogenic Psychiatric-Like Symptoms, Supersensitivity Rebound Psychosis and Withdrawal Discontinuation Syndromes
- (2008) Guy Chouinard et al. PSYCHOTHERAPY AND PSYCHOSOMATICS
- Dopamine D2Highreceptors moderately elevated by bifeprunox and aripiprazole
- (2008) Philip Seeman SYNAPSE
- Dopamine D2High receptors moderately elevated by sertindole
- (2008) Philip Seeman SYNAPSE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started